SHUTi technology, Somryst, receives FDA approval featured in UVA’s Licensing & Ventures Group 2020 Annual Report
April 27, 2021 by School of Medicine Webmaster
- Education
- Research
- Research Home
- Research Departments
- Research Offices
- Research Centers
- Cancer Center
- Cardiovascular Research Center
- Carter Immunology Center
- Center for Behavioral Health & Technology
- Center for Brain Immunology & Glia
- Center for Diabetes Technology
- Center for Immunity, Inflammation & Regenerative Medicine
- Center for Membrane & Cell Physiology
- Center for Research in Reproduction
- Myles H. Thaler Center for AIDS & Human Retrovirus Research
- Child Health Research Center (Pediatrics)
- Division of Perceptual Studies
- Research News: The Making of Medicine
- Research Core Facilities
- Other Research Programs
- Clinical
- Clinical Home
- Anesthesiology
- Dermatology
- Emergency Medicine
- Family Medicine
- Medicine
- Neurology
- Neurosurgery
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Otolaryngology
- Pathology
- Pediatrics
- Physical Medicine & Rehabilitation
- Plastic Surgery, Maxillofacial, & Oral Health
- Psychiatry & Neurobehavioral Sciences
- Radiation Oncology
- Radiology & Medical Imaging
- Surgery
- Urology
- UVA Health: Patient Care
- Diversity
- Faculty
- News
- About